TMO vs. FHLC

Last updated Jun 13, 2026

TMO (Thermo Fisher Scientific Inc.) is a stock, while FHLC (Fidelity MSCI Health Care Index ETF) is Health & Biotech Equities fund tracking the MSCI USA IMI Health Care Index. Over the past 10 years, TMO returned 12.54%/yr vs 9.76%/yr for FHLC. A 0.69 correlation means they provide meaningful diversification when combined.

Performance

TMO vs. FHLC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Thermo Fisher Scientific Inc. (TMO) and Fidelity MSCI Health Care Index ETF (FHLC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TMO achieves a -18.92% return, which is significantly lower than FHLC's 0.03% return. Over the past 10 years, TMO has outperformed FHLC with an annualized return of 12.54%, while FHLC has yielded a comparatively lower 9.76% annualized return.

TMO

• 1D: -1.33%
• 1M: 5.23%
• YTD: -18.92%
• 6M: -17.84%
• 1Y: 13.42%
• 3Y*: -3.43%
• 5Y*: 0.45%
• 10Y*: 12.54%

FHLC

• 1D: -0.13%
• 1M: 4.40%
• YTD: 0.03%
• 6M: 0.58%
• 1Y: 15.99%
• 3Y*: 7.18%
• 5Y*: 4.76%
• 10Y*: 9.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TMO vs. FHLC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TMO Thermo Fisher Scientific Inc.	-18.92%	11.78%	-1.72%	-3.36%	-17.29%	43.54%	43.72%	45.55%	18.21%	35.03%
FHLC Fidelity MSCI Health Care Index ETF	0.03%	15.42%	2.48%	2.58%	-5.55%	20.39%	18.13%	21.94%	4.71%	23.34%

Correlation

The correlation between TMO and FHLC is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.54
Correlation (3Y) Calculated over the trailing 3-year period	0.60
Correlation (5Y) Calculated over the trailing 5-year period	0.65
Correlation (10Y) Calculated over the trailing 10-year period	0.68
Correlation (All Time) Calculated using the full available price history since Oct 24, 2013	0.69

The correlation between TMO and FHLC shifts across timeframes, from 0.54 (1 year) to 0.69 (all time), reflecting how their relationship changes across market environments.

Return for Risk

TMO vs. FHLC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMO

TMO Risk / Return Rank: 54
TMO Sharpe Ratio Rank: 58
TMO Sortino Ratio Rank: 53
TMO Omega Ratio Rank: 51
TMO Calmar Ratio Rank: 53
TMO Martin Ratio Rank: 53

FHLC

FHLC Risk / Return Rank: 34
FHLC Sharpe Ratio Rank: 34
FHLC Sortino Ratio Rank: 37
FHLC Omega Ratio Rank: 32
FHLC Calmar Ratio Rank: 35
FHLC Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMO vs. FHLC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TMO	FHLC	Difference
Sharpe ratio: Return per unit of total volatility	0.43	1.09	-0.67
Sortino ratio: Return per unit of downside risk	0.87	1.72	-0.85
Omega ratio: Gain probability vs. loss probability	1.10	1.19	-0.09
Calmar ratio: Return relative to maximum drawdown	0.43	1.55	-1.12
Martin ratio: Return relative to average drawdown	0.93	3.86	-2.93

TMO vs. FHLC - Sharpe Ratio Comparison

The current TMO Sharpe Ratio is 0.43, which is lower than the FHLC Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of TMO and FHLC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TMO vs. FHLC - Drawdown Comparison

The maximum TMO drawdown since its inception was -71.16%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for TMO and FHLC.

Drawdown Indicators

	TMO	FHLC	Difference
Max Drawdown Largest peak-to-trough decline	-71.16%	-28.76%	-42.40%
Max Drawdown (1Y) Largest decline over 1 year	-31.38%	-10.38%	-21.00%
Max Drawdown (3Y) Largest decline over 3 years	-37.28%	-16.87%	-20.41%
Max Drawdown (5Y) Largest decline over 5 years	-40.95%	-17.73%	-23.22%
Max Drawdown (10Y) Largest decline over 10 years	-40.95%	-28.76%	-12.19%
Current Drawdown Current decline from peak	-28.80%	-3.15%	-25.65%
Average Drawdown Average peak-to-trough decline	-18.11%	-5.19%	-12.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.43%	4.16%	+10.27%

Volatility

TMO vs. FHLC - Volatility Comparison

Thermo Fisher Scientific Inc. (TMO) has a higher volatility of 10.57% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 4.87%. This indicates that TMO's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TMO	FHLC	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.57%	4.87%	+5.70%
Volatility (6M) Calculated over the trailing 6-month period	22.27%	10.50%	+11.77%
Volatility (1Y) Calculated over the trailing 1-year period	31.48%	14.69%	+16.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.20%	15.02%	+12.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.38%	16.84%	+9.54%

Dividends

TMO vs. FHLC - Dividend Comparison

TMO's dividend yield for the trailing twelve months is around 0.37%, less than FHLC's 1.37% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FHLC Fidelity MSCI Health Care Index ETF	1.37%	1.40%	1.51%	1.40%	1.30%	1.16%	1.45%	1.18%	1.38%	1.38%	1.40%	2.07%
TMO Thermo Fisher Scientific Inc.	0.37%	0.30%	0.30%	0.26%	0.22%	0.16%	0.19%	0.23%	0.30%	0.32%	0.43%	0.42%

Frequently Asked Questions

Can I hold both TMO and FHLC in my portfolio?

TMO and FHLC have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TMO or FHLC?

TMO has higher volatility (10.57%) compared to FHLC (4.87%). In terms of maximum drawdown, TMO dropped -71.16% vs FHLC's -28.76%.

Which has better risk-adjusted returns?

FHLC currently has the higher Sharpe Ratio (1.09 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.